Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Experimental Eye Research

• Publication date

  2013-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.exer.2013.03.013PMID 23528535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Propranolol concentrations after oral administration in term and preterm neonates

  2013cited by this paper
• Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains?

  2012cited by this paper
• Author response: Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains?

  2012cited by this paper
• Intercapillary bridging cells: immunocytochemical characteristics of cells that connect blood vessels in the retina.

  2012cited by this paper
• Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.

  2012cited by this paper
• Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

  2012cited by this paper
• Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.

  2012cited by this paper
• A pharmacokinetic study of a combination of beta adrenoreceptor antagonists - in the isolated perfused ovine eye.

  2012cited by this paper
• Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.

  2012cited by this paper
• β-Blocking and racial variation in the severity of retinopathy of prematurity.

  2012cited by this paper
• Propranolol for infantile haemangiomas: a review

  2011cited by this paper
• Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

  2011cited by this paper
• Distribution of Propranolol in Periocular Tissues: A Comparison of Topical and Systemic Administration

  2011cited by this paper
• A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

  2011cited by this paper
• Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

  2011cited by this paper
• Antiangiogenic effects of β2‐adrenergic receptor blockade in a mouse model of oxygen‐induced retinopathy

  2011cited by this paper
• Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy.

  2010cited by this paper
• The mouse retina as an angiogenesis model.

  2010cited by this paper
• Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

  2010cited by this paper
• Application of isoproterenol inhibits diabetic-like changes in the rat retina.

  2010cited by this paper
• Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

  2009cited by this paper
• Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model

  2009cited by this paper
• Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye.

  2009cited by this paper
• Infantile Hemangiomas and Retinopathy of Prematurity: Possible Association

  2009cited by this paper
• Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

  2009cited by this paper
• Current and future ophthalmic drug delivery systems. A shift to the posterior segment.

  2008cited by this paper
• Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.

  2008cited by this paper
• Propranolol for severe hemangiomas of infancy.

  2008cited by this paper
• Localization of alpha 2 receptors in ocular tissues

  2007cited by this paper
• Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability.

  2006cited by this paper
• Effect of norepinephrine on RhoA, MAP kinase, proliferation and VEGF expression in human umbilical vein endothelial cells.

  2006cited by this paper
• The Incidence and Course of Retinopathy of Prematurity: Findings From the Early Treatment for Retinopathy of Prematurity Study

  2005cited by this paper
• Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization

  2005cited by this paper
• Animal models of oxygen-induced retinopathy.

  2003cited by this paper
• A PCR primer bank for quantitative gene expression analysis.

  2003cited by this paper
• Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control.

  2003cited by this paper
• RTPrimerDB: the Real-Time PCR primer and probe database

  2003cited by this paper
• Timolol Concentrations in Rat Ocular Tissues and Plasma After Topical and Intraperitoneal Dosing

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Oxygen-Induced Retinopathy in the Newborn Rat: Morphological and Immunohistological Findings in Animals Treated with Topical Timolol Maleate

  2000cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• Oxygen-induced retinopathy in the mouse.

  1994cited by this paper
• Distribution of topically administered drugs to the posterior segment of rabbit eye.

  1992cited by this paper
• Nonlinear Pharmacokinetics

  1991cited by this paper
• Endothelial Cells and Normal Circulating Haemopoietic Cells Share a Number of Surface Antigens

  1989cited by this paper
• STUDY PROTOCOL Open Access Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity

  year unknowncited by this paper

• Emerging opportunities in ROP therapy: from inhibiting pathological vessel growth to promoting physiological vascularization

  2026cites this paper
• The Long-Standing Problem of Proliferative Retinopathies: Current Understanding and Critical Cues

  2025cites this paper
• Retinopathy of prematurity in the era of precision neonatology: from risk stratification to targeted therapies

  2025cites this paper
• 早产儿视网膜病变治疗药物研究进展

  2025cites this paper
• A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity

  2024cites this paper
• Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model

  2023cites this paper
• Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors

  2022cites this paper
• Neurosensory Alterations in Retinopathy of Prematurity: A Window to Neurological Impairments Associated to Preterm Birth

  2022cites this paper
• Blocking Ocular Sympathetic Activity Inhibits Choroidal Neovascularization

  2022cites this paper
• Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1α via the PI3K/Akt/ERK pathway

  2022cites this paper
• β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo

  2021cites this paper
• The Anti-Inflammatory Effect of the β1-Adrenergic Receptor Antagonist Metoprolol on High Glucose Treated Human Microvascular Retinal Endothelial Cells

  2021cites this paper
• Ocular Versus Oral Propranolol for Prevention and/or Treatment of Oxygen-Induced Retinopathy in a Rat Model

  2021cites this paper
• A safety review of drugs used for the treatment of retinopathy of prematurity

  2020cites this paper
• Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa

  2020cites this paper
• Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions

  2020cites this paper
• Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study

  2020cites this paper
• Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study

  2019cites this paper
• Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis

  2019cites this paper
• Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity

  2019cites this paper
• Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study

  2019cites this paper
• Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy.

  2018cites this paper
• Propranolol for Proliferative Diabetic Retinopathy.

  2018cites this paper
• The progress of prophylactic treatment in retinopathy of prematurity.

  2018cites this paper
• The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when?

  2018cites this paper
• The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy

  2017cites this paper
• Study of the effects of β-adrenergic receptor agonists and antagonists on pericyte survival in retinopathies

  2017influential citation
• Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial

  2017cites this paper
• THE EFFECT OF TOPICAL BEVACIZUMAB ON CORNEAL NEOVASULARIZATION IN A RABBIT MODEL

  2017cites this paper
• Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial

  2017cites this paper
• β2–Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression

  2017cites this paper
• Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation

  2017cites this paper
• Neuroprotection as a Therapeutic Target for Diabetic Retinopathy

  2016cites this paper
• Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion

  2016cites this paper
• Periocular Tissue Concentrations of Propranolol after Ocular Instillation of a Gel-Forming Solution.

  2016cites this paper
• Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients

  2016cites this paper
• 2 . Neurodegeneration in DR and the Role of VEGF

  2016cites this paper
• Surface plasmon resonance analysis.

  2016cites this paper
• Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.

  2015cites this paper
• Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β‐Adrenergic System

  2015cites this paper
• Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy

  2015cites this paper
• Preventative Strategies in the Management of ROP: A Review of Literature

  2015cites this paper
• Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.

  2015cites this paper
• Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.

  2015cites this paper
• Oral Propranolol: A New Treatment for Infants with Retinopathy of Prematurity?

  2015cites this paper
• Prävention und Therapie der Retinopathia praematurorum

  2015cites this paper
• Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization.

  2015cites this paper
• Pharmacokinetics and local safety profile of propranolol eye drops in rabbits

  2014cites this paper
• The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases.

  2014cites this paper
• Protective Effects of b 1 / 2 Adrenergic Receptor Deletion in a Model of Oxygen-Induced Retinopathy

  2014cites this paper
• Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.

  2014cites this paper
• Protective effects of β1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy.

  2014cites this paper
• Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

  2013cites this paper